Compare $RCEL vs $USBC | Chartloom

Compare

$RCEL vs $USBC

AVITA Medical Inc · USBC Inc

RCEL

AVITA Medical Inc

USBC

USBC Inc

Compare $RCEL vs $USBC

Comparing AVITA Medical Inc and USBC Inc

RCELAVITA Medical Inc

USBCUSBC Inc

RCELAVITA Medical Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.05x

Rev growth (TTM)

1.0%

YTD performance

280.7%

52W performance

139.7%

FCF yield

-6.2%

USBCUSBC Inc

Market cap

$198M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-51.9%

FCF yield

-11.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RCEL

USBC

Detailed metrics comparison

RCEL

AVITA Medical Inc

USBC

USBC Inc

Market Cap

RCEL$407M

USBC$198M

Enterprise Value

RCEL$444M

USBC$210M

Price

RCEL$13.21

USBC$0.51

P/E Ratio

RCELN/A

USBCN/A

P/S Ratio

RCEL5.38x

USBC0.00x

EV/Sales

RCEL5.87x

USBC0.00x

EV/EBITDA

RCEL0.00x

USBC0.00x

P/B Ratio

RCEL87.44x

USBC4.46x

P/FCF Ratio

RCELN/A

USBCN/A

EV/FCF

RCEL-17.54x

USBC-9.14x

PEG Ratio

RCELN/A

USBCN/A

Forward P/E (NTM)

RCELN/A

USBCN/A

Forward P/S (NTM)

RCEL4.05x

USBCN/A

Revenue (TTM)

RCEL$76M

USBC$0

Revenue Growth (YoY)

RCEL1.0%

USBCN/A

Forward Rev Growth

RCEL20.3%

USBC0.0%

Gross Margin (TTM)

RCEL82.1%

USBC0.0%

Operating Margin (TTM)

RCEL0.0%

USBC0.0%

EBITDA Margin (TTM)

RCEL-41.9%

USBC0.0%

Net Margin (TTM)

RCEL-57.0%

USBC0.0%

FCF Margin (TTM)

RCEL-33.5%

USBCN/A

Net Income (TTM)

RCEL$-43M

USBC$-86M

FCF (TTM)

RCEL$-25M

USBC$-23M

EPS (TTM)

RCEL-$1.40

USBC-$0.22

ROE (TTM)

RCEL-33790.0%

USBC-12093.0%

ROA (TTM)

RCEL-7853.0%

USBC-9639.0%

ROIC (TTM)

RCEL-10295.0%

USBC-11297.0%

Cash

RCEL$9M

USBC$3M

Debt

RCEL$47M

USBC$15M

Net Cash/Debt

RCEL$-38M

USBC$-12M

Current Ratio (TTM)

RCEL0.41x

USBC0.23x

Quick Ratio (TTM)

RCEL0.31x

USBC0.20x

Debt/Equity (TTM)

RCEL9.39x

USBC0.32x

Debt/Assets (TTM)

RCEL0.0%

USBC0.0%

Interest Coverage (TTM)

RCELN/A

USBCN/A

Net Debt/EBITDA (TTM)

RCEL0.00x

USBC0.00x

Beta

RCEL2.07

USBC2.77

52W Performance

RCEL139.7%

USBC-51.9%

YTD Performance

RCEL280.7%

USBC-22.2%

% from 52W High

RCEL-3.7%

USBC-60.5%

% from 52W Low

RCEL310.2%

USBC78.7%

Asset Turnover (TTM)

RCEL1.38x

USBC0.00x

FCF Yield (TTM)

RCEL-6.2%

USBC-11.6%

Earnings Yield (TTM)

RCEL-10.6%

USBC-43.5%

Dividend Yield (TTM)

RCELN/A

USBCN/A

Rule of 40

RCEL-32.5

USBC0.0

EV/GP/RG

RCEL0.22

USBCN/A

Ticker research

View RCEL research View USBC research

Metric	RCEL AVITA Medical Inc	USBC USBC Inc
Market & Valuation
Market Cap	$407M	$198M
Enterprise Value	$444M	$210M
Price	$13.21	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	5.38x	0.00x
EV/Sales	5.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	87.44x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.54x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.05x	N/A
Revenue & Growth
Revenue (TTM)	$76M	$0
Revenue Growth (YoY)	1.0%	N/A
Forward Rev Growth	20.3%	0.0%
Profitability
Gross Margin (TTM)	82.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41.9%	0.0%
Net Margin (TTM)	-57.0%	0.0%
FCF Margin (TTM)	-33.5%	N/A
Net Income (TTM)	$-43M	$-86M
FCF (TTM)	$-25M	$-23M
EPS (TTM)	-$1.40	-$0.22
ROE (TTM)	-33790.0%	-12093.0%
ROA (TTM)	-7853.0%	-9639.0%
ROIC (TTM)	-10295.0%	-11297.0%
Financial Health
Cash	$9M	$3M
Debt	$47M	$15M
Net Cash/Debt	$-38M	$-12M
Current Ratio (TTM)	0.41x	0.23x
Quick Ratio (TTM)	0.31x	0.20x
Debt/Equity (TTM)	9.39x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	2.77
52W Performance	139.7%	-51.9%
YTD Performance	280.7%	-22.2%
% from 52W High	-3.7%	-60.5%
% from 52W Low	310.2%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	1.38x	0.00x
FCF Yield (TTM)	-6.2%	-11.6%
Earnings Yield (TTM)	-10.6%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-32.5	0.0
EV/GP/RG	0.22	N/A
Ticker research	View RCEL research	View USBC research

Valuation

P/S Ratio

USBC

0.00x

RCEL

5.38x

EV/FCF

RCEL

-17.54x

USBC

-9.14x

Growth & revenue

Revenue Growth TTM

RCEL

1.0%

Forward Revenue Growth

RCEL

20.3%

USBC

0.0%

Profitability & performance

Gross Margin

RCEL

82.1%

USBC

0.0%

ROE

USBC

-12093.0%

RCEL

-33790.0%

FCF Yield %

RCEL

-6.2%

USBC

-11.6%

52-Week Performance

RCEL

139.7%

USBC

-51.9%

Detailed metrics comparison

RCEL

AVITA Medical Inc

USBC

USBC Inc

Market Cap

RCEL$407M

USBC$198M

Enterprise Value

RCEL$444M

USBC$210M

Price

RCEL$13.21

USBC$0.51

P/E Ratio

RCELN/A

USBCN/A

P/S Ratio

RCEL5.38x

USBC0.00x

EV/Sales

RCEL5.87x

USBC0.00x

EV/EBITDA

RCEL0.00x

USBC0.00x

P/B Ratio

RCEL87.44x

USBC4.46x

P/FCF Ratio

RCELN/A

USBCN/A

EV/FCF

RCEL-17.54x

USBC-9.14x

PEG Ratio

RCELN/A

USBCN/A

Forward P/E (NTM)

RCELN/A

USBCN/A

Forward P/S (NTM)

RCEL4.05x

USBCN/A

Revenue (TTM)

RCEL$76M

USBC$0

Revenue Growth (YoY)

RCEL1.0%

USBCN/A

Forward Rev Growth

RCEL20.3%

USBC0.0%

Gross Margin (TTM)

RCEL82.1%

USBC0.0%

Operating Margin (TTM)

RCEL0.0%

USBC0.0%

EBITDA Margin (TTM)

RCEL-41.9%

USBC0.0%

Net Margin (TTM)

RCEL-57.0%

USBC0.0%

FCF Margin (TTM)

RCEL-33.5%

USBCN/A

Net Income (TTM)

RCEL$-43M

USBC$-86M

FCF (TTM)

RCEL$-25M

USBC$-23M

EPS (TTM)

RCEL-$1.40

USBC-$0.22

ROE (TTM)

RCEL-33790.0%

USBC-12093.0%

ROA (TTM)

RCEL-7853.0%

USBC-9639.0%

ROIC (TTM)

RCEL-10295.0%

USBC-11297.0%

Cash

RCEL$9M

USBC$3M

Debt

RCEL$47M

USBC$15M

Net Cash/Debt

RCEL$-38M

USBC$-12M

Current Ratio (TTM)

RCEL0.41x

USBC0.23x

Quick Ratio (TTM)

RCEL0.31x

USBC0.20x

Debt/Equity (TTM)

RCEL9.39x

USBC0.32x

Debt/Assets (TTM)

RCEL0.0%

USBC0.0%

Interest Coverage (TTM)

RCELN/A

USBCN/A

Net Debt/EBITDA (TTM)

RCEL0.00x

USBC0.00x

Beta

RCEL2.07

USBC2.77

52W Performance

RCEL139.7%

USBC-51.9%

YTD Performance

RCEL280.7%

USBC-22.2%

% from 52W High

RCEL-3.7%

USBC-60.5%

% from 52W Low

RCEL310.2%

USBC78.7%

Asset Turnover (TTM)

RCEL1.38x

USBC0.00x

FCF Yield (TTM)

RCEL-6.2%

USBC-11.6%

Earnings Yield (TTM)

RCEL-10.6%

USBC-43.5%

Dividend Yield (TTM)

RCELN/A

USBCN/A

Rule of 40

RCEL-32.5

USBC0.0

EV/GP/RG

RCEL0.22

USBCN/A

Ticker research

View RCEL research View USBC research

Metric	RCEL AVITA Medical Inc	USBC USBC Inc
Market & Valuation
Market Cap	$407M	$198M
Enterprise Value	$444M	$210M
Price	$13.21	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	5.38x	0.00x
EV/Sales	5.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	87.44x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.54x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.05x	N/A
Revenue & Growth
Revenue (TTM)	$76M	$0
Revenue Growth (YoY)	1.0%	N/A
Forward Rev Growth	20.3%	0.0%
Profitability
Gross Margin (TTM)	82.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41.9%	0.0%
Net Margin (TTM)	-57.0%	0.0%
FCF Margin (TTM)	-33.5%	N/A
Net Income (TTM)	$-43M	$-86M
FCF (TTM)	$-25M	$-23M
EPS (TTM)	-$1.40	-$0.22
ROE (TTM)	-33790.0%	-12093.0%
ROA (TTM)	-7853.0%	-9639.0%
ROIC (TTM)	-10295.0%	-11297.0%
Financial Health
Cash	$9M	$3M
Debt	$47M	$15M
Net Cash/Debt	$-38M	$-12M
Current Ratio (TTM)	0.41x	0.23x
Quick Ratio (TTM)	0.31x	0.20x
Debt/Equity (TTM)	9.39x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	2.77
52W Performance	139.7%	-51.9%
YTD Performance	280.7%	-22.2%
% from 52W High	-3.7%	-60.5%
% from 52W Low	310.2%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	1.38x	0.00x
FCF Yield (TTM)	-6.2%	-11.6%
Earnings Yield (TTM)	-10.6%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-32.5	0.0
EV/GP/RG	0.22	N/A
Ticker research	View RCEL research	View USBC research